Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

NCT03774394 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease (CKD)
Type 2 Diabetes Mellitus (T2DM)
Coronary Artery Disease (CAD)

Interventions

DRUG: Clopidogrel
DRUG: Clopidogrel active metabolite

Sponsor

University of Florida

Collaborators

[object Object]